NCT03735121 2025-12-05A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung CancerHoffmann-La RochePhase 3 Completed438 enrolled 40 charts 1 FDA